Accelerating Drug Discovery and Genomic Research
Stanford Scientists Launch Biomni AI Co-Scientist
New autonomous agent speeds up genomic data analysis and drug discovery hypotheses from hours to minutes.
A scientist in a modern laboratory looking at a computer screen that displays complex genomic data and colorful DNA visualizations.
Photo: Avantgarde News
Researchers at Stanford University have introduced Biomni, an autonomous AI agent designed to serve as a research partner for the biomedical sciences [1]. The system can analyze complex genomic data and generate visualizations in minutes, significantly reducing the time required for tasks that typically take human scientists dozens of hours [1][2].
Biomni performs at an expert level by identifying plausible hypotheses and executing deep research tasks [2]. This agentic approach is part of a broader effort to use artificial intelligence to accelerate scientific discovery and enhance lab productivity [1][3].
Experts suggest that these agentic scientists are on a course to reshape the drug discovery landscape [3]. The Stanford team is expected to present further details on the system's impact at upcoming industry conferences in 2026 [3].
Editorial notes
Transparency note
AI assisted drafting. Human edited and reviewed.
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
Reviewed for sourcing quality and editorial consistency.
Sources
- 1.↗
hai.stanford.edu
https://hai.stanford.edu/news/how-ai-is-accelerating-scientific-discovery
- 2.↗
bioworld.com
https://www.bioworld.com/articles/732620-ai-co-scientist-performs-biomedical-research-at-expert-level-in-less-time
- 3.↗
venturebeat.com
https://venturebeat.com/data/stanford-researchers-will-discuss-their-agentic-scientists-that-are-on-course-to-reshape-drug-discovery-at-vb-transform-2026
Related stories
View all
Topics
About the author
Avantgarde News Desk covers accelerating drug discovery and genomic research and editorial analysis for Avantgarde News.